Karlson, Elizabethjpg
This speaker appears at this event:

This speaker’s events are being finalized

Elizabeth Karlson, MD

  • Senior Physician, BH
  • Professor, Medicine, HMS

Dr. Elizabeth Karlson is a Professor of Medicine at Harvard Medical School, and a rheumatologist and epidemiologist at Brigham and Women’s Hospital. She is co-Director of the Partners HealthCare Biobank, co-Principal Investigator of the All of Us Research Program, for the New England Precision Medicine Consortium and co-Principal Investigator of the Harvard eMERGE Clinical Center. She serves as Director of the Rheumatic Disease Epidemiology Research Program for the Section of Clinical Sciences, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Brigham and Women’s Hospital.

Dr. Karlson’s research interests are in rheumatic disease epidemiology and outcomes, genetics, gene-environment interactions, and bioinformatics analysis of electronic health records for clinical and translational research. She is funded by the National Institutes of Health for translational epidemiology, electronic health record and bioinformatics research studies as well as Human Biosample Research Cores. She leads recruitment for the Partners HealthCare Biobank that aims to collect samples, family history, lifestyle and environmental survey data linked with comprehensive health information from electronic health records from 200,000 Partners HealthCare patients. She coordinates bioinformatics analyses for phenotype algorithms for the Biobank Portal and eMERGE network. She has served on grant review committees for the National Institutes of Health, Arthritis Foundation, and national grant agencies in Canada and Europe. She has served on the American College of Rheumatology Blue Ribbon Panel on Academic Rheumatology. She has received the Henry Kunkel Young Investigator Award, the Excellence in Investigative Mentoring Award from the American College of Rheumatology, and the Senior Faculty Mentoring Award from the Brigham and Women’s Hospital.

Covid-19 Broadcast
May 11, 2020
Live Event
May 10–12, 2021